Additionally, we found that use of low affinity CD19 (Supplementary Fig. 2A) and CD229 (Supplementary Fig. 2B) CARs had also resulted in substantially reduced transfer of the respective target antigen from the tumor cells to the CAR T cells. Here, CD19 is linked to neoplasm.